CAPR icon

Capricor Therapeutics

19 hedge funds and large institutions have $3.25M invested in Capricor Therapeutics in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 3 reducing their positions, and 3 closing their positions.

Holders
19
Holders Change
-2
Holders Change %
-9.52%
% of All Funds
0.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
6
Reduced
3
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
Brown Advisory
1
Brown Advisory
Maryland
$1.52M 1,136,755
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.06M 787,994 +75,461 +11%
CBA
3
Coastal Bridge Advisors
Connecticut
$160K 119,591
Geode Capital Management
4
Geode Capital Management
Massachusetts
$159K 118,686 +41,690 +54%
VF
5
Virtu Financial
New York
$76K 56,760 +4,350 +8%
AA
6
Apriem Advisors
California
$67K 50,000
Northern Trust
7
Northern Trust
Illinois
$62K 45,919 +7,259 +19%
BlackRock
8
BlackRock
New York
$59K 43,496 +39,377 +956%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$34K 25,097 -1,665 -6%
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$16K 11,949 -48,804 -80%
HIIFS
11
Harel Insurance Investments & Financial Services
Israel
$9K 6,959
Bank of America
12
Bank of America
North Carolina
$7K 5,500
PA
13
Perceptive Advisors
New York
$5K 4,000
CFN
14
Cordasco Financial Network
Florida
$4K 3,100
LTFS
15
Ladenburg Thalmann Financial Services
Florida
$4K 2,700
FANJ
16
Financial Architects (New Jersey)
New Jersey
$3K 2,000
AG
17
Advisor Group
Arizona
$3K 2,000 +2,000 New
UBS Group
18
UBS Group
Switzerland
$2K 1,264 +864 +216%
BAM
19
Belpointe Asset Management
Nevada
-72,286 Closed
Deutsche Bank
20
Deutsche Bank
Germany
-600 Closed
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$0 225 -7 -3%
Morgan Stanley
22
Morgan Stanley
New York
-2 -100%